Breaking News Instant updates and real-time market news.

OMER

Omeros

$19.61

(0.00%)

09:09
05/07/19
05/07
09:09
05/07/19
09:09

Omeros says clinical study shows reduced incidence of CME with OMIDRIA

Omeros Corporation announced the results of a real-world clinical study showing that its FDA-approved ophthalmic drug OMIDRIA 1% / 0.3% decreases the incidence of postoperative cystoid macular edema, a sight-threatening complication of cataract surgery. The study results were presented at the joint annual meeting of the American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators. The investigator-sponsored study was conducted by Keith A. Walter, M.D., Professor of Ophthalmology at Wake Forest University School of Medicine. He conducted a retrospective analysis of 504 eyes on whom he had performed cataract surgery using OMIDRIA plus only a topical non-steroidal anti-inflammatory drug, assessing the incidence of CME. The control group consisted of a collection of single and meta-analytic studies published in the peer-reviewed literature in which steroids, with and without topical NSAIDs, were used in cataract surgery in the absence of OMIDRIA. Of the 504 eyes treated with OMIDRIA, only two developed postoperative CME, an incidence of 0.39 percent, which is 3- to 12-fold lower than the CME rates in the published peer-reviewed studies using steroids both with and without NSAIDs in the absence of OMIDRIA. A manuscript reporting details of the study is in preparation and is expected to be submitted for publication in a peer-reviewed journal.

  • 09

    May

  • 07

    Jun

OMER Omeros
$19.61

(0.00%)

10/15/18
HCWC
10/15/18
NO CHANGE
Target $34
HCWC
Buy
Omeros selloff on data brings attractive entry point, say H.C. Wainwright
Data released earlier this month from a Phase 2 trial of OMS721, Omeros's most advanced clinical candidate, appear to have created some confusion in the market as the company's share price has fallen roughly 50% since the announcement, H.C. Wainwright analyst Raghuram Selvaraju tells investors in a research note. The selloff is unwarranted, says the analyst, who reiterates a Buy rating on the shares with a $34 price target. He points out that the data were from a small trial that was not designed to deliver statistical significance or definitive evidence of efficacy. Further, the "data itself were encouraging, not discouraging, and there certainly was no evidence of any safety concern or toxicity issue that would have jeopardized OMS721's future development," Selvaraju writes.
05/06/19
CANT
05/06/19
INITIATION
CANT
Overweight
Omeros initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated Omeros with an Outperform and $26 price target.
05/06/19
CANT
05/06/19
INITIATION
Target $26
CANT
Overweight
Omeros initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Brandon Folkes initiated coverage of Omeros with an Overweight rating and $26 price target. The analyst believes investors can be rewarded from current levels through the company's pipeline alone. As such, the risk/reward is to the upside, "creating a compelling investment opportunity," Folkes tells investors in a research note.
05/06/19
05/06/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. PagerDuty (PD) initiated with an Overweight at Piper Jaffray, with a Neutral at BTIG, with an Outperform at William Blair, with an Overweight at JPMorgan, with a Sector Weight at KeyBanc, with an Equal Weight at Morgan Stanley and with a Sector Perform at RBC Capital. 2. Tufin (TUFN) initiated with a Buy at Jefferies, with an Overweight at Piper Jaffray, with a Market Perform at William Blair, with a Hold at Stifel, with an Outperform at Oppenheimer, with an Overweight at JPMorgan and with an Overweight at Barclay. 3. Aclaris Therapeutics (ACRS) initiated with an Outperform at SVB Leerink. 4. Jumia Technologies (JMIA) initiated with a Neutral at Citi and with a Sector Perform at RBC Capital. 5. Omeros (OMER) initiated with an Overweight at Cantor Fitzgerald. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MYL

Mylan

$19.67

0.225 (1.16%)

16:30
05/21/19
05/21
16:30
05/21/19
16:30
Hot Stocks
FDA: Mylan broadens recall of Valsartan tablets »

Mylan N.V.External Link…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

16:30
05/21/19
05/21
16:30
05/21/19
16:30
Options
Preliminary option volume of 15.0M today »

Preliminary option volume…

CDAY

Ceridian

$51.19

1.04 (2.07%)

16:29
05/21/19
05/21
16:29
05/21/19
16:29
Syndicate
Ceridian files to sell 8M shares of common stock for holders »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IT

Gartner

$154.12

1.62 (1.06%)

16:25
05/21/19
05/21
16:25
05/21/19
16:25
Hot Stocks
Gartner VP Robin Kranich sellls over $980K in company shares »

Gartner VP Robin Kranich…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 03

    Jun

  • 05

    Jun

PSTG

Pure Storage

$20.60

0.6 (3.00%)

16:22
05/21/19
05/21
16:22
05/21/19
16:22
Hot Stocks
Pure Storage down 17% to $17.10 after Q1 results miss estimates »

The company's Q2 and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

  • 20

    Jun

  • 09

    Jul

EXPR

Express

$3.45

0.08 (2.37%)

16:21
05/21/19
05/21
16:21
05/21/19
16:21
Hot Stocks
Express appoints Timothy Baxter CEO »

Express announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 12

    Jun

  • 18

    Jun

OOMA

Ooma

$14.49

-0.45 (-3.01%)

16:20
05/21/19
05/21
16:20
05/21/19
16:20
Earnings
Ooma narrows FY20 EPS view to (24c)-(19c) from (24c)-(14c), consensus (19c) »

Raises FY20 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

  • 10

    Jun

AVP

Avon Products

$3.20

0.06 (1.91%)

16:20
05/21/19
05/21
16:20
05/21/19
16:20
Options
Avon Products put buyer closes out long term trade »

Avon Products put buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/21/19
05/21
16:20
05/21/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 21st »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRBI

Red River Bancshares

$49.95

(0.00%)

16:19
05/21/19
05/21
16:19
05/21/19
16:19
Initiation
Red River Bancshares initiated  »

Red River Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRNS

Transcat

$24.25

0.13 (0.54%)

16:17
05/21/19
05/21
16:17
05/21/19
16:17
Hot Stocks
Transcat sees FY20 CapEx $7.8M-$9.2M »

Transcat expects its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

AYR

Aircastle

$20.03

0.275 (1.39%)

16:17
05/21/19
05/21
16:17
05/21/19
16:17
Hot Stocks
Aircastle raises repurchase program up to $100M from $76M »

Aircastle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 05

    Jun

  • 13

    Nov

OOMA

Ooma

$14.49

-0.45 (-3.01%)

16:17
05/21/19
05/21
16:17
05/21/19
16:17
Earnings
Ooma sees Q2 EPS (7c) to (5c), consensus (4c) »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

  • 10

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/21/19
05/21
16:17
05/21/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRNS

Transcat

$24.25

0.13 (0.54%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Earnings
Transcat reports Q4 EPS 35c, consensus 29c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

RDNT

RadNet

$13.62

0.37 (2.79%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Hot Stocks
RadNet officer John Crues sells 20K shares of company stock »

RadNet officer John Crues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

PRSP

Perspecta

$22.33

0.36 (1.64%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Hot Stocks
Perspecta increases quarterly dividend 20% »

Perspecta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

LIQT

LiqTech

$9.29

-0.21 (-2.21%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Syndicate
LiqTech files to sell common stock, no amount given »

Stephens Inc. is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

LIQT

LiqTech

$9.29

-0.21 (-2.21%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Syndicate
LiqTech files to sell common stock, no amount given »

Stephens is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

OOMA

Ooma

$14.49

-0.45 (-3.01%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Earnings
Ooma reports Q EPS (4c), consensus (5c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

  • 10

    Jun

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LFUS

Littelfuse

$170.78

1.7 (1.01%)

16:15
05/21/19
05/21
16:15
05/21/19
16:15
Initiation
Littelfuse initiated  »

Littelfuse initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

LUV

Southwest

$53.37

1.37 (2.63%)

16:15
05/21/19
05/21
16:15
05/21/19
16:15
Hot Stocks
Southwest says new AMFA contract 'benefits all parties' »

Southwest Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 25

    Jul

  • 13

    Nov

URBN

Urban Outfitters

$27.01

0.05 (0.19%)

16:13
05/21/19
05/21
16:13
05/21/19
16:13
Earnings
Urban Outfitters reports Q1 EPS 31c, consensus 25c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 04

    Jun

SMTC

Semtech

$44.66

0.28 (0.63%)

16:12
05/21/19
05/21
16:12
05/21/19
16:12
Initiation
Semtech initiated  »

Semtech initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 13

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.